Synthetic Biologics, Inc. (SYN)
NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.5500-0.0301 (-5.19%)
At close: 4:00PM EST
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 0.5801 |
| Open | 0.5700 |
| Bid | 0.5920 x 1100 |
| Ask | 0.6000 x 1400 |
| Day's Range | 0.4600 - 0.5800 |
| 52 Week Range | 0.2500 - 1.7000 |
| Volume | 17,227,395 |
| Avg. Volume | 19,297,708 |
| Market Cap | 71.31M |
| Beta (5Y Monthly) | 2.03 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.7020 |
| Earnings Date | Mar 04, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.25 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
View moreRelated Research
- PR Newswire
Synthetic Biologics Reports 2020 Year End Operational Highlights and Financial Results
Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, today provided a clinical programs update and reported financial results for the year ended December 31, 2020.
- ACCESSWIRE
Synthetic Biologics, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / March 4, 2021 / Synthetic Biologics, Inc. (NYSE:SYN) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 4, 2021 at 4:30 PM Eastern Time.
- Simply Wall St.
How Many Synthetic Biologics, Inc. (NYSEMKT:SYN) Shares Did Insiders Buy, In The Last Year?
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
© 2021 Verizon Media. All rights reserved.
